Before any COVID-19 vaccines can be made available in South Africa, they must be authorised by South Africa’s medicines regulator—the South African Health Products Regulatory Authority (SAHPRA). Catherine Tomlinson explores how SAHPRA is preparing to review and authorise the use of COVID-19 vaccines in the country and the different authorisation approaches they may use.
Almost half of the most commonly used medications to treat mental illness in South Africa were out of stock in August, and many have been in short supply since March. Now, experts warn that amid the COVID-19 outbreak, the nation could see a “shadow epidemic” of psychiatric illness. Laura Lopez Gonzalez investigates.
Over the last decade the treatment of hepatitis C, a virus that can infect and damage the liver, has been revolutionised by a new class of medicines called direct acting antivirals. Catherine Tomlinson investigates the regulatory obstacles that are limiting access to these breakthrough medicines in South Africa.